On Jan. 31, 2023, Partner Winston Kirton will moderate the Biotechnology Innovation Organization (BIO) “Clinical Trial Diversity Roundtable: Analyzing the Data We Have Today, Enhancing Data Sources and Infrastructure for the Future, and Building a Diverse Workforce.”
The daylong virtual event is a follow-up to the BIO Clinical Trial Diversity Summit held in June 2021 and will feature solution-oriented perspectives from the Food and Drug Administration, patient groups, industry, health technology organizations and other stakeholders.
Registration is free.
For more information and to register.